In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: Role of phosphodiesterase type 5 phosphorylation

Molecular Biology of the Cell

Volumn 15, Issue 9, 2004, Pages 4023-4030

  Mullershausen, Florian ^a   Russwurm, Michael ^a   Koesling, Doris ^a   Friebe, Andreas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SENSITIVE GUANYLATE CYCLASE; PHOSPHODIESTERASE V; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL LINE; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVATION; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME REGULATORY DOMAIN; GAF DOMAIN; HUMAN; HUMAN CELL; HUMAN EMBRYONIC KIDNEY CELL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; CELL LINE; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; FEEDBACK; GENE EXPRESSION; GUANYLATE CYCLASE; HUMANS; KINETICS; NITRIC OXIDE; PHOSPHORYLATION; RECOMBINANT PROTEINS; S-NITROSOGLUTATHIONE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 4344587810     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-12-0890     Document Type: Article

References (22)

1. Bellamy, T.C., Wood, J., Goodwin, D.A., and Garthwaite, J. (2000). Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl. Acad. Sci. USA 97, 2928-2933.
2. Corbin, J.D., Blount, M.A., Weeks, J.L., 2nd, Beasley, A., Kuhn, K.P., Ho, Y.S., Saidi, L.F., Hurley, J.H., Kotera, J., and Francis, S.H. (2003). [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP. Mol. Pharmacol. 63, 1364-1372.
3. Corbin, J.D., Turko, I.V., Beasley, A., and Francis, S.H. (2000). Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur. J. Biochem. 267, 2760-2767.
4. Francis, S.H., Bessay, E.P., Kotera, J., Grimes, K.A., Liu, L., Thompson, W.J., and Corbin, J.D. (2002). Phosphorylation of isolated human phosphodiesterase-5 regulatory domain induces an apparent conformational change and increases cGMP binding affinity. J. Biol. Chem. 277, 47581-47587.
5. Francis, S.H., Turko, I.V., and Corbin, J.D. (2000). Cyclic nucleotide phosphodiesterases: relating structure and function. Prog. Nucleic. Acid. Res. Mol. Biol. 65, 1-52.
6. Friebe, A., and Koesling, D. (2003). Regulation of nitric oxide-sensitive guanylyl cyclase. Circ. Res. 93, 96-105.
7. Friebe, A., Mullershausen, F., Smolenski, A., Walter, U., Schultz, G., and Koesling, D. (1998), YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol. Pharmacol. 54, 962-967.
8. Gibb, B.J., Wykes, V., and Garthwaite, J. (2003). Properties of NO-activated guanylyl cyclases expressed in cells. Br. J. Pharmacol. 139, 1032-1040.
9. Juilfs, D.M., Soderling, S., Burns, F., and Beavo, J.A. (1999). Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs). Rev. Physiol. Biochem. Pharmacol. 135, 67-104.
10. Martinez, S.E., Wu, A.Y., Glavas, N.A., Tang, X.B., Turley, S., Hol, W.G., and Beavo, J.A. (2002). The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. Proc. Natl. Acad. Sci. USA 99, 13260-13265.
11. McAllister-Lucas, L.M., et al. (1993). The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J. Biol. Chem. 268, 22863-22873.
12. Mergia, E., Zoidl, G., Russwurm, M., and Koesling, D. (2003). Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain. Cell Signal 15, 189-195.
13. Mullershausen, F., Friebe, A., Feil, R., Thompson, W.J., Hofmann, F., and Koesling, D. (2003). Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling. J. Cell Biol. 160, 719-727.
14. Mullershausen, F., Russwurm, M., Thompson, W.J., Liu, L. Koesling, D., and Friebe, A. (2001). Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme. J. Cell Biol. 155, 271-278.
15. Okada, D., and Asakawa, S. (2002). Allosteric activation of cGMP-specific, cGMP-binding phosphodiesterase (PDE5) by cGMP. Biochemistry 41, 9672-9679.
16. Russwurm, M., Wittau, N., and Koesling, D. (2001). Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J. Biol. Chem. 276, 44647-44652.
17. Rybalkin, S.D., Rybalkina, I.G., Feil, R., Hofmann, F., and Beavo, J.A. (2002). Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells. J. Biol. Chem. 277, 3310-3317.
18. Rybalkin, S.D., Rybalkina, I.G., Shimizu-Albergine, M., Tang, X.B., and Beavo, J.A. (2003). PDE5 is converted to an activated state upon cGMP binding to the GAF A domain. EMBO J. 22, 469-478.
19. Shimizu-Albergine, M., Rybalkin, S.D., Rybalkina, I.G., Feil, R., Wolfsgruber, W., Hofmann, F., and Beavo, J.A. (2003). Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation. J. Neurosci. 23, 6452-6459.
20. Turko, I.V., Francis, S.H., and Corbin, J.D. (1998). Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation. Biochem. J. 329, 505-510.
21. Wyatt, T.A., Naftilan, A.J., Francis, S.H., and Corbin, J.D. (1998). ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am. J. Physiol. 274, 448-455.
22. Wykes, V., Bellamy, T.C., and Garthwaite, J. (2002). Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP. J. Neurochem. 83, 37-47.